Seelos Therapeutics Inc (SEEL) Quote

SEEL new 52 week low

Buying here???

SEEL new 52 week low

SEEL new 52 week low

Newer one today...

I guess I'll just wait till it goes under a buck to take a shot..........

SEEL new 52 week low

Is it worth it at this point to start a position?

TIA

8-k RS 1-8

https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/93868824/form-8-k-current-report

I’ve never owned a stock with 2 Reverse Splits.

SELL new 52+ lo

SEEL new 52 week low

SEEL new 52 lo

Down 31%. Close $0.6279. WTH.

SEEL 10Q due March 12

Pretty sad.

SEEL new 52 week low

SELL Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
https://www.prnewswire.com/news-releases/seelos-therapeutics-inc-announces-4-0-million-registered-direct-offering-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules-302045669.html

8-K https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/93010517/form-8-k-current-report

Form 4 https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92986476/form-4-statement-of-changes-in-beneficial-owners

I voted No to Proxy. More dilution planned and increase in outstanding shares.

$1.66, up 7%.

“Thank you”

You are a master of two word messages all over Ihub.

back to DUMPING I see

Form 4 https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92705677/form-4-statement-of-changes-in-beneficial-owners

PRE-14A https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92718397/form-pre-14a-other-preliminary-proxy-statements

Close $1.96, up 42%.

RELENTESS BUYING. HOD $2.17.

$1.35, UP. RELENTLESS BUYING.

8-K

https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92695438/form-8-k-current-report

INCONTROVERTIBLE DUMPING

Form 424B5 - Prospectus [Rule 424(b)(5)]

https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92670943/form-424b5-prospectus-rule-424b5

CONSTANT “DUMPING” by 👇👇👇

https://investorshub.advfn.com/boards/profile.aspx?user=114150

ANNOYING DUMPING

What an annoying asshole

INDEFATIGABLE SELLING

RELENTLESS DUMPING

RS 1:30 tomorrow. I’m holding. Never know if good news is released.

UNYIELDING DUMPING

Seelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)

PUBLISHED
NOV 27, 2023 8:00AM EST

https://www.nasdaq.com/press-release/seelos-therapeutics-announces-the-selection-of-sls-002-intranasal-racemic-ketamine

News out.

SEEL will retain it’s Nasdaq standing.

11.03.2023 8-K Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On November 1, 2023, Seelos Therapeutics, Inc. (the “Company”) received written notice (the “First Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until April 29, 2024, to regain compliance. The First Notice states that the Nasdaq staff will provide written confirmation that the Company has achieved compliance with Rule 5550(a)(2) if at any time before April 29, 2024, the bid price of the Company’s common stock closes at $1.00 per share or more for a minimum of ten consecutive business days.

lod $0.1065.

Wow, $0.139.

SLS-005 ALS results due by year end

Any possible catalyst here?

About ready to avg. down but waiting for a dip to .17 area.

.199 now.

SEEL.....from .1651 to .2020 in 4 days is good enough for me